Literature DB >> 12751635

Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung.

Jennifer Fiegel1, Carsten Ehrhardt, Ulrich Friedrich Schaefer, Claus-Michael Lehr, Justin Hanes.   

Abstract

PURPOSE: The ability to optimize new formulations for pulmonary delivery has been limited by inadequate in vitro models used to mimic conditions particles encounter in the lungs. The aim is to develop a physiologically-relevant model of the pulmonary epithelial barrier that would allow for quantitative characterization of therapeutic aerosols in vitro.
METHODS: Calu-3 human bronchial epithelial cells were cultured on permeable filter inserts under air-interfaced culture (AIC) and liquid-covered culture (LCC) conditions. Calu-3 cells grown under both conditions formed tight monolayers and appeared physiologically similar by SEM and immunocytochemical staining against cell junctional proteins and prosurfactant protein-C.
RESULTS: Aerosolized large porous particles (LPP) deposited homogeneously and reproducibly on the cell surface and caused no apparent damage to cell monolayers by SEM and light microscopy. However, monolayers initially grown under LCC conditions showed a significant decrease in barrier properties within the first 90 min after impingement with microparticles, as determined by transepithelial electrical resistance (TEER) measurements and fluorescein-sodium transport. Conversely, AIC grown monolayers showed no significant change in barrier properties within the first 90 min following particle application. A dense mucus coating was found on AIC grown Calu-3 monolayers, but not on LCC grown monolayers, which may protect the cell surface during particle impinging.
CONCLUSION: This in vitro model, based on AIC grown Calu-3 cells, should allow a more relevant and quantitative characterization of therapeutic aerosol particles intended for delivery to the tracheobronchial region of the lung or to the nasal passages. Such characterization is likely to be particularly important with therapeutic aerosol particles designed to provide sustained drug release in the lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751635     DOI: 10.1023/a:1023441804464

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium.

Authors:  K A Foster; M Yazdanian; K L Audus
Journal:  J Pharm Pharmacol       Date:  2001-01       Impact factor: 3.765

2.  Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies.

Authors:  K J Elbert; U F Schäfer; H J Schäfers; K J Kim; V H Lee; C M Lehr
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 3.  Delivery of biotherapeutics by inhalation aerosol.

Authors:  R W Niven
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1995       Impact factor: 4.889

4.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells.

Authors:  M E Cavet; M West; N L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

5.  In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery.

Authors:  C Witschi; R J Mrsny
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

6.  Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).

Authors:  B I Florea; I C van der Sandt; S M Schrier; K Kooiman; K Deryckere; A G de Boer; H E Junginger; G Borchard
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

7.  Cultures of bovine tracheal epithelium with differentiated ultrastructure and ion transport.

Authors:  M Kondo; W E Finkbeiner; J H Widdicombe
Journal:  In Vitro Cell Dev Biol       Date:  1993-01

8.  Serial culturing of human bronchial epithelial cells derived from biopsies.

Authors:  P M de Jong; M A van Sterkenburg; J A Kempenaar; J H Dijkman; M Ponec
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

9.  Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung.

Authors:  J Bastacky; C Y Lee; J Goerke; H Koushafar; D Yager; L Kenaga; T P Speed; Y Chen; J A Clements
Journal:  J Appl Physiol (1985)       Date:  1995-11

10.  Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion.

Authors:  B Q Shen; W E Finkbeiner; J J Wine; R J Mrsny; J H Widdicombe
Journal:  Am J Physiol       Date:  1994-05
View more
  21 in total

Review 1.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

2.  Epithelial profiling of antibiotic controlled release respiratory formulations.

Authors:  Hui Xin Ong; Daniela Traini; Mary Bebawy; Paul Michael Young
Journal:  Pharm Res       Date:  2011-05-26       Impact factor: 4.200

Review 3.  Cells and Culture Systems Used to Model the Small Airway Epithelium.

Authors:  Rudra Bhowmick; Heather Gappa-Fahlenkamp
Journal:  Lung       Date:  2016-04-12       Impact factor: 2.584

4.  Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier.

Authors:  Christopher I Grainger; Leona L Greenwell; David J Lockley; Gary P Martin; Ben Forbes
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

5.  The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model.

Authors:  Aileen Gibbons; Danielle Padilla-Carlin; Ciara Kelly; Anthony J Hickey; Clifford Taggart; Noel G McElvaney; Sally-Ann Cryan
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

6.  Chapter 9 - Nanoliposomal dry powder formulations.

Authors:  Gaurang Patel; Mahavir Chougule; Mandip Singh; Ambikanandan Misra
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

7.  Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses.

Authors:  Yan Zhu; Aaron Chidekel; Thomas H Shaffer
Journal:  Crit Care Res Pract       Date:  2010-06-27

8.  In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.

Authors:  Mehra Haghi; Daniela Traini; Paul Young
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

9.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

10.  A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles.

Authors:  Anke Gabriele Lenz; Erwin Karg; Bernd Lentner; Vlad Dittrich; Christina Brandenberger; Barbara Rothen-Rutishauser; Holger Schulz; George A Ferron; Otmar Schmid
Journal:  Part Fibre Toxicol       Date:  2009-12-16       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.